ID   CCCL-1
AC   CVCL_J320
SY   C85
DR   Wikidata; Q54808773
RX   PubMed=10428757;
RX   PubMed=11589301;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 26 hours (PubMed=10428757); 24 hours (PubMed=11589301).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 9
//
RX   PubMed=11589301; DOI=10.3727/096504001108747756;
RA   Longo, Giuseppe S.A.
RA   Izzo, Julie
RA   Gorlick, Richard Greg
RA   Banerjee, Debabrata
RA   Jhanwar, Suresh C.
RA   Bertino, Joseph Rocco
RT   "Characterization and drug sensitivity of four newly established colon
RT   adenocarcinoma cell lines to antifolate inhibitors of thymidylate
RT   synthase.";
RL   Oncol. Res. 12:309-314(2001).
//
RX   PubMed=10428757; DOI=10.1096/fasebj.13.11.1325;
RA   Kooby, David A.
RA   Carew, John F.
RA   Halterman, Marc Whitney
RA   Mack, Jonathan E.
RA   Bertino, Joseph Rocco
RA   Blumgart, Leslie H.
RA   Federoff, Howard J.
RA   Fong, Yu-Man
RT   "Oncolytic viral therapy for human colorectal cancer and liver
RT   metastases using a multi-mutated herpes simplex virus type-1 (G207).";
RL   FASEB J. 13:1325-1334(1999).
//